Literature DB >> 1517279

Molecular-genetic analysis of ocular adnexal benign lymphoid hyperplasias by a two-step polymerase-chain-reaction.

Y Takano1, M Okudaira.   

Abstract

Twelve biopsied ocular adnexal benign lymphoid hyperplasias (OABLH) satisfying benign histological criteria were investigated for clonal immunoglobulin (Ig) heavy-chain gene rearrangement by means of a two-step polymerase chain reaction (PCR) method using formalin-fixed and paraffin-embedded tissue. Of the 12, 4 (33%) demonstrated clear single bands of the rearranged gene for the Ig heavy-chain, of between 100 and 150 base pairs. The selected cases were all free of malignant lymphoma and all of the lesions were small (2 x 2-22 x 6 mm; median 4.5 x 3 mm). Histopathological and cytological features were not essentially different between monoclonal and non-monoclonal examples. Immunohistochemistry was of little benefit in separating the two. It is concluded that OABLH demonstrating a benign clinical course frequently contain monoclonal B cell populations suggesting a continuous progressive spectrum of lesions in B cell neoplasia. In addition, the significance of molecular-genetic analysis for OABLH and the utility of the two-step PCR method should be emphasized.

Entities:  

Mesh:

Year:  1992        PMID: 1517279     DOI: 10.1007/bf01211800

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  22 in total

1.  The histopathology of the macroglobulinemia of Waldenström.

Authors:  T F DUTCHER; J L FAHEY
Journal:  J Natl Cancer Inst       Date:  1959-05       Impact factor: 13.506

2.  Rapid method for distinguishing clonal from polyclonal B cell populations in surgical biopsy specimens.

Authors:  K P McCarthy; J P Sloane; L M Wiedemann
Journal:  J Clin Pathol       Date:  1990-05       Impact factor: 3.411

3.  Purification of DNA from formaldehyde fixed and paraffin embedded human tissue.

Authors:  S E Goelz; S R Hamilton; B Vogelstein
Journal:  Biochem Biophys Res Commun       Date:  1985-07-16       Impact factor: 3.575

4.  The expression of surface antigen Leu 1 by ocular adnexal lymphoid neoplasms.

Authors:  D M Knowles; F A Jakobiec; C Y Wang
Journal:  Am J Ophthalmol       Date:  1982-08       Impact factor: 5.258

5.  Immunologic characterization of ocular adnexal lymphoid neoplasms.

Authors:  D M Knowles; F A Jakobiec; J P Halper
Journal:  Am J Ophthalmol       Date:  1979-05       Impact factor: 5.258

6.  Immunoglobulin-gene rearrangements as unique clonal markers in human lymphoid neoplasms.

Authors:  A Arnold; J Cossman; A Bakhshi; E S Jaffe; T A Waldmann; S J Korsmeyer
Journal:  N Engl J Med       Date:  1983-12-29       Impact factor: 91.245

7.  Lymphomas and pseudolymphomas of the alimentary tract. An immunohistochemical study with clinicopathologic correlations.

Authors:  P Saraga; J Hurlimann; L Ozzello
Journal:  Hum Pathol       Date:  1981-08       Impact factor: 3.466

8.  Clinical, morphologic, immunophenotypic, and molecular genetic analysis of bilateral ocular adnexal lymphoid neoplasms in 17 patients.

Authors:  L McNally; F A Jakobiec; D M Knowles
Journal:  Am J Ophthalmol       Date:  1987-04-15       Impact factor: 5.258

9.  Lymphoid infiltrates of the orbit and conjunctiva. A morphologic and immunophenotypic study of 99 cases.

Authors:  L J Medeiros; N L Harris
Journal:  Am J Surg Pathol       Date:  1989-06       Impact factor: 6.394

10.  Histopathological and immunohistochemical study of atypical lymphoid hyperplasia and benign lymphoid hyperplasia of the stomach.

Authors:  Y Takano; Y Kato; H Sugano
Journal:  Jpn J Cancer Res       Date:  1992-03
View more
  2 in total

1.  Clonal B cell populations in a minority of patients with Hashimoto's thyroiditis.

Authors:  A Saxena; E C Alport; O Moshynska; R Kanthan; M A Boctor
Journal:  J Clin Pathol       Date:  2004-12       Impact factor: 3.411

2.  Epstein-Barr-virus-associated medullary carcinomas with lymphoid infiltration of the stomach.

Authors:  Y Takano; Y Kato; H Sugano
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.